Skip to content

Investors

Grow with Eve.

Eve & Co is a Canadian company focused on the emerging female-focused cannabis market. Our common shares are publicly traded on the Toronto Venture Exchange under the name “EVE.”

Eve & Co Incorporated, through its wholly owned subsidiary Natural MedCo Ltd., is a licensed producer and seller of dried cannabis and cannabis plants under the Access to Cannabis for Medical Purposes Regulations (ACMPR).

As the cannabis industry matures, Eve & Co will continue to provide educational information and online support for its customers and first-time buyers.

For more information, contact investor relations at invest@naturalmedco.ca.

Executive Team

Melinda Rombouts - President, CEO

Prior to founding NMC, Ms. Rombouts was the president, manager and owner of numerous large scale businesses producing agricultural food and pharmaceutical related products. Through this experience she has gained extensive plants knowledge crucial to the growth of a healthy plant and high quality product.

Ms. Rombouts has grown hundreds of varieties of plants and has experience with quality assurance and GPP program development, implementation and improvement with strict adherence to the regulations governing the pharmaceutical industry.

Jacqueline Scott - Chief Financial Officer

Ms. Scott joined NMC in March 2018. Her previous work experience includes five years as Chief Financial Officer for a manufacturer of agricultural products in Petrolia, Ontario and 20 years as Chief Financial Officer for Sydenham Community Credit Union (now Mainstreet Credit Union) in Strathroy.

She also previously acted as member of the board and Treasurer for both Participation House Support Services, London and WOTCH (now CMHA Middlesex.)

Ms. Scott is a Chartered Professional Accountant, Certified General Accountant and graduated with a B. Mathematics from the University of Waterloo.

Shobana Thaya - Investor Relations

Ms. Thaya is a principal at Vertex Strategies Inc. specializing in Canadian investor relationships and corporate communications.

Ms. Thaya has extensive knowledge and investor relations experience in the cannabis sector and played an integral role in the initial public offering in what is now one of Canada’s leading large cap cannabis companies.

Ms. Thaya holds a Bachelor of Commerce degree from Ryerson University and is currently pursuing the executive MBA at IVEY School of Business at University of Western Ontario.

Mehraneh Ebrahimi - Director

Dr. Ebrahimi is the head of academic research of her family’s investment business, which olds various interests in agricultural, real estate and private equities. Prior to that, she taught at Western University in London, Ontario, where she received her PhD in World Literature.

Speaking four languages and conducting research on the role of the disenfranchised, women, and minorities in world affairs have helped Dr. Ebrahimi understand the unique international cultural kaleidoscope of Canada.

She is the recipient of several teaching awards and scholarships and the author of a forthcoming book entitled Women, Art and Literature in Diaspora. Her diverse experiences both academic and managerial shape her understanding of business and social life, especially women and immigrants.

T.A. Clark Moeller IV - Director

Mr. Moeller lives in Wichita, Kansas and is the head of EQ Development, a company focussed on private equity investments. With a background in lodging, commercial and residential real estate development, Mr. Moeller also has extensive experience in business operations across a wide variety of segments.

Mr. Moeller has broad experience in the cannabis industry with investments in Canada and the Colorado market.

Mr. Moeller graduated with honors and received his B.A. in United States History from the University of Kansas.

Jonathan Pollack - Director

Jonathan Pollack is the President of the JMP Group, a private investment and consulting firm. He is also a director of several public and private companies including CECO Environmental Corp (NASDAQ:CEDE). Mr. Pollack also served as a director of API Technologies Corp. (NASDAQ:ATNY), Pinetree Capital Ltd. (TSX:PNP), Hanfeng Evergreen Inc. (TSX:HF) and Lifebank Corp. (TSXV:LBK).

From March 2005 through its sale in 2009, he served as the Chief Financial Officer and Corporate Secretary of Kaboose Inc. Prior thereto, he worked in investment banking in New York.

Mr. Pollack sits on the boards of several philanthropic organizations including the Mt. Sinai Hospital Foundation, the Crescent School Foundation, and the Sterling Hall School Foundation.

Ravi Sood - Director

Mr. Sood is the managing director of Signal 8 Limited. Mr. Sood has been a founder of and the principal investor in several businesses in emerging markets and currently serves as Executive Chairman and Director of Galene Gold Ltd. (TSXV:GG) and Blockchain Power Trust (TSXV:BPWR) and as a director of Feronia Inc. (TSXV:FRN), and ICC Labs Inc. (TSXV:ICC).

He was the founder and Chief Executive Officer of Navina Asset Management Inc., a global asset management firm headquartered in Toronto, Canada. Mr. Sood led the investment activities of Navina and its predecessor company, Lawrence Asset Management Inc., from its founding in 2001 until he sold the firm in 2010.

Michael Young - Director

Mr. Young has extensive senior level executive management and trading experience in the Canadian and U.S. capital markets. He is currently Managing Partner of Cottingham Capital LLC, a property investment and development company.

Throughout his career in finance and banking, he has built a strong network of Canadian, American and international investors.

Most recently, he held the position of Managing Director and Co-Head of Trading for GMP Securities L.P. in Toronto, a leading independent investment dealer headquartered in Toronto, providing investment banking, institutional sales and trading and research to a global client base.

Investor News

Eve & Co. Incorporated Opens the Market

August 2, 2018

Eve & Co. Rings the TSX Bell Thursday, July 26, 2018 marked an exciting day for Eve & Co Incorporated as Melinda Rombouts, President and ...

Learn More

MOU Signed With B.C. for Distribution of Cannabis to the Recreational Market

July 12, 2018

Eve & Co Signs MOU With British Columbia for Distribution of Cannabis to the Recreational Market Eve & Co Incorporated (the “Company” or “EVE”) (TSXV:EVE) ...

Learn More

Eve & Co Incorporated Begins Trading on the TSX Venture Exchange

July 4, 2018

Eve & Co Incorporated (the “Company” or “EVE”) (TSXV:EVE) is pleased to announce that at the opening of the market today, EVE’s common shares will ...

Learn More

Eve & Co Incorporated Announces Closing of Qualifying Transaction

June 28, 2018

TORONTO, June 28, 2018 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (formerly Carlaw Capital V Corp.) (the “Company”) or “Eve & Co”) (NEX:CVC.H) is pleased ...

Learn More

Natural MedCo Receives Sales License for Medicinal Cannabis and Announces New “Eve” Brand

June 25, 2018

TORONTO, June 25, 2018 (GLOBE NEWSWIRE) -- Carlaw Capital V Corp. (“Carlaw”) (NEX:CVC.H) is pleased to announce that 1600978 Ontario Inc. (which operates as Natural ...

Learn More

Natural MedCo and Carlaw Capital V Corp. Announce Closing of $20.8 Million Financing and SEDAR Filing of Filing Statement

June 18, 2018

TORONTO, June 18, 2018 (GLOBE NEWSWIRE) -- 1600978 Ontario Inc. (which operates as Natural MedCo) (“NMC”) and Carlaw Capital V Corp. (the “Corporation”) (NEX:CVC.H) are ...

Learn More

Natural MedCo and Carlaw Capital V Corp. Provide Update on Qualifying Transaction

June 14, 2018

NMC and Carlaw enter into an amalgamation agreement NMC announces proposed terms of equity private placements of approximately $10,800,000 and convertible debenture private placement of ...

Learn More

Carlaw Capital V Corp. Announces Reverse Take-Over by Natural Med Company

December 18, 2017

December 18, 2017 07:00 ET Carlaw Capital V Corp. Announces Reverse Take-Over by Natural Med Company TORONTO, ONTARIO--(Marketwired - Dec. 18, 2017) - Carlaw Capital V ...

Learn More